Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

HIV Infection

Free Subscription 27.10.2025 1 AIDS 1 Blood 1 BMC Pediatr 1 BMJ 3 Clin Infect Dis 4 HIV Med 1 Int J Cancer 7 J Acquir Immune Defic Syndr 1 J Clin Invest 1 J Infect Dis 1 J Med Virol 5 PLoS One 2 PLoS Pathog 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. SCOTT J, Anglemyer A, Ong JJ, Kumbaroff Z, et al
   A systematic review of models used to estimate undiagnosed HIV prevalence in high income low prevalence countries and territories.
   AIDS. 2025 Oct 23. doi: 10.1097/QAD.0000000000004390.
   PubMed         Abstract available
   
   

   
   Blood

2. JUM'AH H, Feldman AL
   KSHV/HHV8-positive germinotropic lymphoproliferative disorder in a patient with HIV.
   Blood. 2025;146:2145.
   PubMed        
   
   

   
   BMC Pediatr

3. FARHADI K, Zomorodi AR, Hassannezhad M, Mohebi S, et al
   Extended spectrum beta-lactamase and integron genes among Shigella flexneri and Shigella sonnei isolated from children with diarrhea in shiraz, Southwest Iran.
   BMC Pediatr. 2025;25:832.
   PubMed         Abstract available
   
   

   
   BMJ

4. WISE J
   HIV prevention injection to be rolled out in England after NICE approval.
   BMJ. 2025;391:r2190.
   PubMed        
   
   

   
   Clin Infect Dis

5. MANABE YC, Hamill MM, Palamountain KM, Achenbach CJ, et al
   The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of Human Immunodeficiency Virus Nucleic Acid Assays in the United States.
   Clin Infect Dis. 2025 Oct 23:ciaf510. doi: 10.1093.
   PubMed         Abstract available
   
   
6. MINGCHAY P, Kawkitinarong K, Torvorapanit P, Ohata PJ, et al
   Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial).
   Clin Infect Dis. 2025 Oct 23:ciaf580. doi: 10.1093.
   PubMed         Abstract available
   
   
7. PATEL K, Jaramillo-Underwood A, Karalius B, Yao TJ, et al
   Integrase Strand Transfer Inhibitors for Treatment-experienced Young Adults With Perinatal HIV in the US: Immunologic, Virologic, and Anthropometric Outcomes.
   Clin Infect Dis. 2025 Oct 22:ciaf538. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   HIV Med

8. POYNTEN IM, Turner RC, Varma R, Costello J, et al
   Australian guidelines for anal cancer screening using anal human papillomavirus testing with cytology triage in people living with HIV.
   HIV Med. 2025 Oct 23. doi: 10.1111/hiv.70133.
   PubMed         Abstract available
   
   
9. SUKUMARAN L, Winston A, Marzolini C, Khoo S, et al
   Polypharmacy in HIV: Rethinking what counts and why it matters.
   HIV Med. 2025 Oct 21. doi: 10.1111/hiv.70129.
   PubMed         Abstract available
   
   
10. TROYA J, Montes ML, Galindo MJ, Santiago AD, et al
    Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort.
    HIV Med. 2025 Oct 21. doi: 10.1111/hiv.70114.
    PubMed         Abstract available
    
    
11. DAYALAN N, Leung S, Dahill K, Temple A, et al
    Integrase inhibitors and paclitaxel for Kaposi sarcoma: Clinical relevance of pharmacological interaction.
    HIV Med. 2025 Oct 19. doi: 10.1111/hiv.70130.
    PubMed        
    
    

    
    Int J Cancer

12. ZHENG Y, Han J, Qu Y, Wang J, et al
    Circulating cell-free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV-positive Nigerian population.
    Int J Cancer. 2025 Oct 23. doi: 10.1002/ijc.70204.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

13. D K, C R, B C, H RG, et al
    Factors Associated with Preference for Long-Acting Injectable versus Daily Oral Antiretroviral Therapy among People with HIV: Findings from the SELIGO Study.
    J Acquir Immune Defic Syndr. 2025 Oct 22. doi: 10.1097/QAI.0000000000003781.
    PubMed         Abstract available
    
    
14. ISLEK D, Sanchez T, Baral S, Caldwell JA, et al
    Characteristics associated with the HIV Pre-exposure prophylaxis care continuum among transfeminine persons in the United States.
    J Acquir Immune Defic Syndr. 2025 Oct 22. doi: 10.1097/QAI.0000000000003783.
    PubMed         Abstract available
    
    
15. WEINSTEIN ER, Kirakosian N, Chen YO, Bharat B, et al
    Life Instability and its Effects on Psychosocial Syndemic Problems and HIV-Care Outcomes in People Living with HIV in Care in South Florida.
    J Acquir Immune Defic Syndr. 2025 Oct 9. doi: 10.1097/QAI.0000000000003777.
    PubMed         Abstract available
    
    
16. ORKIN C, Kuritzkes DR, Katlama C, Su FH, et al
    Doravirine Resistance Patterns Identified through Week 192 in the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Clinical Trials.
    J Acquir Immune Defic Syndr. 2025 Oct 23. doi: 10.1097/QAI.0000000000003787.
    PubMed         Abstract available
    
    
17. LARSON ME, Pan Y, Lakhani F, Chavez J, et al
    The association between cannabis use and electrocardiographic abnormalities in people living with HIV.
    J Acquir Immune Defic Syndr. 2025 Oct 23. doi: 10.1097/QAI.0000000000003786.
    PubMed         Abstract available
    
    
18. ADESSE D, Torices S, Alcaide ML, Beurel E, et al
    Plasma biomarkers of neurogenesis are increased among people with HIV after COVID.
    J Acquir Immune Defic Syndr. 2025 Oct 23. doi: 10.1097/QAI.0000000000003785.
    PubMed         Abstract available
    
    
19. MAGONGO EN, Hast M, Nabitaka V, Nakanwagi M, et al
    Low Levels of Clinically Significant Drug Resistance Mutations to Dolutegravir amongst Children Living with HIV Failing on First-line Antiretroviral Therapy in Uganda.
    J Acquir Immune Defic Syndr. 2025 Oct 23. doi: 10.1097/QAI.0000000000003784.
    PubMed         Abstract available
    
    

    
    J Clin Invest

20. DRAGONI F, Sop J, Gurumurthy I, Beckey TP, et al
    Selective targeting of HIV infected clones by cognate peptide stimulation and antiproliferative drugs.
    J Clin Invest. 2025 Oct 21:e197266. doi: 10.1172/JCI197266.
    PubMed         Abstract available
    
    

    
    J Infect Dis

21. COX S, Andreatta K, Hendricks MR, Li J, et al
    Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies.
    J Infect Dis. 2025 Oct 24:jiaf533. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

22. OFFICER A, Meng W, Spellman D, Martin J, et al
    Oral Microbiome and Inferred Functions Predict Kaposi's Sarcoma Progression.
    J Med Virol. 2025;97:e70647.
    PubMed         Abstract available
    
    

    
    PLoS One

23. LEONE AM, Saidi F, Graybill LA, Li Q, et al
    Alignment of PrEP adherence and HIV exposure risk among pregnant and postpartum women in Lilongwe, Malawi.
    PLoS One. 2025;20:e0335429.
    PubMed         Abstract available
    
    
24. AEMIRO A, Girma A, Alamnie G, Beletew D, et al
    Prevalence of opportunistic bacterial infections (tuberculosis and pneumonia) among people with HIV in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2025;20:e0315599.
    PubMed         Abstract available
    
    
25. OLUWAGBEMI OO, Onyeka E, Jatto A, Oluwagbemi FE, et al
    Multilingual voice-enabled informatics tools: Catalyst for equitable AI in HIV and HIV-comorbidity healthcare management.
    PLoS One. 2025;20:e0332573.
    PubMed         Abstract available
    
    
26. BEYRER C, Remien RH, Eshleman SH, Gamble TR, et al
    Investigating the HIV epidemic among Black gay and bisexual men in the Southern United States: Results of the HPTN 096 pilot cross-sectional assessment.
    PLoS One. 2025;20:e0334031.
    PubMed         Abstract available
    
    
27. DE LA COURT F, Ten Hoff DOT, Prins M, Hoornenborg E, et al
    Oral pre-exposure prophylaxis retention among men who have sex with men and transgender persons: Systematic review and meta-analysis.
    PLoS One. 2025;20:e0333494.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

28. GROSSKOPF AK, Tobiasson V, Krug LT
    Eph receptor tyrosine kinases are functional entry receptors for murine gammaherpesvirus 68.
    PLoS Pathog. 2025;21:e1013263.
    PubMed         Abstract available
    
    
29. GROBBEN M, Reiss EIMM, Schriek AI, van der Straten K, et al
    Induction of HIV-1-specific antibody-mediated effector functions by native-like envelope trimers in humans.
    PLoS Pathog. 2025;21:e1013614.
    PubMed         Abstract available
    
    

    
    Vaccine

30. KILLANDER MOLLER I, Hedberg P, Wagner P, Sparen P, et al
    Corrigendum to "Sociodemographic factors influencing SARS-CoV-2 vaccination uptake in people with and without HIV: Insights from a Swedish Nationwide cohort" [Vaccine 62 (2025) 127580].
    Vaccine. 2025;67:127855.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.